Epstein-Barr virus gH is essential for penetration of B cells but also plays a role in attachment of virus to epithelial cells

Journal of Virology

Volumn 74, Issue 14, 2000, Pages 6324-6332

  Molesworth, Sara J ^a   Lake, Cathleen M ^a   Borza, Corina M ^a   Turk, Susan M ^a   Hutt Fletcher, Lindsey M ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT RECEPTOR; GLYCOPROTEIN; GREEN FLUORESCENT PROTEIN; HLA ANTIGEN CLASS 2; MACROGOL; THYMIDINE KINASE;

ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENE CASSETTE; GENE EXPRESSION; HUMAN; HUMAN CELL; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; VIRUS CELL INTERACTION; VIRUS INFECTION;

ANIMALS; B-LYMPHOCYTES; BLOTTING, SOUTHERN; BLOTTING, WESTERN; CELL LINE; EPITHELIAL CELLS; GLYCOPROTEINS; HEMAGGLUTININS, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; MEMBRANE GLYCOPROTEINS; MOLECULAR CHAPERONES; MUTAGENESIS, SITE-DIRECTED; OPEN READING FRAMES; POLYETHYLENE GLYCOLS; RECEPTORS, COMPLEMENT 3D; RECOMBINATION, GENETIC; SHEEP; VIRAL PROTEINS;

EID: 0033918948     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.14.6324-6332.2000     Document Type: Article

References (40)

1. Babic, N., B. G. Klupp, B. Makoschey, A. Karger, A. Flamand, and T. C. Mettenleiter. 1996. Glycoprotein gH of pseudorabies virus is essential for penetration and propagation in cell culture and in the nervous system of mice. J. Gen. Virol. 77:2277-2285.
2. Baer, R., A. T. Bankier, M. D. Biggin, P. L. Deininger, P. J. Farrell, T. J. Gibson, G. Hatfull, G. S. Hudson, S. C. Satchwell, C. Seguin, P. S. Tuffnell, and B. G. Barrell. 1984. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310:207-211.
3. Bonnet, M., J.-M. Guinebretiere, E. Kremmer, V. Grunewald, E. Benhamou, G. Contesso, and I. Joab. 1999. Detection of Epstein-Barr virus in invasive breast cancers. J. Natl. Cancer Inst. 91:1376-1381.
4. Borza, C., and L. M. Hutt-Fletcher. 1998. Epstein-Barr virus recombinant lacking expression of glycoprotein gplSO infects B cells normally but is enhanced for infection of the epithelial line SVKCR2. J. Virol. 72:7577-7582.
5. Fingeroth, J. D., M. E. Diamond, D. R. Sage, J. Hayman, and J. L. Yates. 1999. CD-21 dependent infection of an epithelial cell line, 293, by Epstein-Barr virus. J. Virol. 73:2115-2125.
6. Fingeroth, J. D., J. J. Weis, T. F. Tedder, J. L. Strominger, P. A. Biro, and D. T. Fearon. 1984. Epstein-Barr virus receptor of human B lymphocytes is the C3d complement CR2. Proc. Natl. Acad. Sci. USA 81:4510-4516.
7. Forrester, A., H. Farrell, G. Wilkinson, J. Kaye, N. Davis-Poynter, and T. Minson. 1992. Construction and properties of a mutant of herpes simplex virus type 1 with glycoprotein H coding sequences deleted. J. Virol. 66:341-348.
8. Gardella, T., P. Medveczky, T. Sairenji, and C. Mulder. 1984. Detection of circular and linear herpesvirus DNA molecules in mammalian cells by gel electrophoresis. J. Virol. 50:248-254.
9. Greenspan, J. S., D. Greenspan, E. T. Lennette, D. I. Abrams, M. A. Conant, V. Petersen, and U. K. Freese. 1985. Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion. New Engl. J. Med. 313:1504-1571.
10. Haan, K. M., W. W. Kwok, R. Longnecker, and P. Speck. 2000. Epstein-Barr virus entry utilizing HLA-DP or HLA-DQ as a coreceptor. J. Virol. 74:2451-2454.
11. Haddad, R. S., and L. M. Hutt-Fletcher. 1989. Depletion of glycoprotein gp85 from virosomes made with Epslein-Barr virus proteins abolishes their ability to fuse with virus receptor-bearing cells. J. Virol. 63:4998-5005.
12. Heineman, T., M. Gong, J. Sample, and E. Kieff. 1988. Identification of the Epstein-Barr virus gp85 gene. J. Virol. 62:1101-1107.
13. Hoffman, G. J., S. G. Lazarowitz, and S. D. Hayward. 1980. Monoclonal antibody against a 250,000-dalton glycoprotein of Epstein-Barr virus identifies a membrane antigen and a neutralizing antigen. Proc. Natl. Acad. Sci. USA 77:2979-2983.
14. Hurley, E. A., and D. A. Thorley-Lawson. 1988. B cell activation and the establishment of Epstein-Barr virus latency. J. Exp. Med. 168:2059-2075.
15. Imai, S., J. Nishikawa, and K. Takada. 1998. Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells. J. Virol. 72:4371-4378.
16. Li, Q. X., M. K. Spriggs, S. Kovats, S. M. Turk, M. R. Comeau, B. Nepom, and L. M. Hutt-Fletcher. 1997. Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes. J. Virol. 71:4657-4662.
17. Li, Q. X., S. M. Turk, and L. M. Hutt-Fletcher. 1995. The Epstein-Barr virus (EBV) BZLF2 gene product associates with the gH and gL homologs of EBV and carries an epitope critical to infection of B cells hut not of epithelial cells. J. Virol. 69:3987-3994.
18. Li, Q. X., L. S. Young, G. Niedobitek, C. W. Dawson, M. Birkenbach, F. Wang, and A. B. Rickinson. 1992. Epstein-Barr virus infection and replication in a human epithelial system. Nature 356:347-350.
19. Liebowitz, D. 1994. Nasopharyngeal carcinoma: the Epstein-Barr virus association. Semin. Oncol. 21:376-381.
20. Mackett, M., M. J. Conway, J. R. Arrand, R. S. Haddad, and L. M. Hutt-Fletcher. 1990. Characterization and expression of a glycoprotein encoded by the Epstein-Barr virus BamHI 1 fragment. J. Virol. 64:2545-2552.
21. Meyer, G., E. Hanon, D. Georlette, P. P. Pastoret, and E. Thiry. 1998. Bovine herpesvirus type 1 glycoprotein H is essential for penetration and propagation in cell culture. J. Gen. Virol. 79:1983-1987.
22. Miller, N., and L. M. Hutt-Fletcher. 1988. A monoclonal antibody to glycoprotein gp85 inhibits fusion but not attachment of Epstein-Barr virus. J. Virol. 62:2366-2372.
23. Moore, M. D., R. G. DiScipio, N. R. Cooper, and G. R. Nemerow. 1989. Hydrodynamic, electron microscopic and ligand binding analysis of the Epstein-Barr virus/C3dg receptor (CR2). J. Biol. Chem. 34:20576-20582.
24. Nemerow, G. R., C. Mold, V. Keivens Schwend, V. Tollefson, and N. R. Cooper. 1987. Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV/C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3d. J. Virol. 61:1416-1420.
25. Nemerow, G. R., R. Wolfert, M. McNaughton, and N. R. Cooper. 1985. Identification and characterization of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2). J. Virol. 55:347-351.
26. Oba, D. E., and L. M. Hutt-Fletcher. 1988. Induction of antibodies to the Epstein-Barr virus glycoprotein gp85 with a synthetic peptide corresponding to a sequence in the BXLF2 open reading frame. J. Virol. 62:1108-1114.
27. Osato, T., and S. Imai. 1996. Epstein-Barr virus and gastric carcinoma. Semin. Cancer Biol. 7:175-182.
28. Parker, B. D., A. T. Bankier, S. C. Satchwell, B. G. Barrell, and P. J. Farrell. 1990. Sequence and transcription of Raji Epstein-Barr virus DNA spanning the B95-8 deletion region. Virology 179:339-346.
29. Peeters, B., N. Dewind, R. Broer, A. Gielkins, and R. Moormann. 1992. Glycoprotein H of pseudorabies virus is essential for entry and cell-ta-cell spread of the virus. J. Virol. 66:3888-3892.
30. Schroder, C., and G. M. Keil. 1999. Bovine herpesvirus 1 requires glycoprotein H for infectivity and direct spreading and glycoproteins gH (W450) and gB for glycoprotein D-independent cell-to-cell spread. J. Gen. Virol. 80:57-61.
31. Shimizu, N., H. Yoshiyama, and K. Takada. 1996. Clonal propagation of Epstein-Barr virus (EBV) recombinants in EBV-negative Akata cells. J. Virol. 70:7260-7263.
32. Spriggs, M. K., R. J. Armitage, M. R. Comeau, L. Strockbine, T. Farrah, B. MacDuff, D. Ulrich, M. R. Alderson, J. Mullberg, and J. I. Cohen. 1996. The extracellular domain of the Epstein-Barr virus BZLF2 protein binds the HLA-DR beta chain and inhibits antigen presentation. J. Virol. 70:5557-5563.
33. Takada, K. 1984. Cross-linking of cell surface immunoglohulin induces Epstein-Barr virus in Burkitt lymphoma lines. Int. J. Cancer. 33:27-32.
34. Tanner, J., J. Weis, D. Fearon, Y. Whang, and E. Kieff. 1987. Epstein-Barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping and endocytosis. Cell 50:203-213.
35. Thorley-Lawson, D. A., E. M. Miyashita, and G. Khan. 1996. Epstein-Barr virus and the B cell: that's all it takes. Trends Microbiol. 4:204-208.
36. Wang, X., and L. M. Hutt-Fletcher. 1998. Epstein-Barr virus lacking glycoprotein gp42 can bind to B cells but is not able to infect. J. Virol. 72:158-163.
37. Wang, X., W. J. Kenyon, Q. X. Li, J. Mullberg, and L. M. Hutt-Fletcher. 1998. Epstein-Barr virus uses different complexes of glycoproteins gH and gL to infect B lymphocytes and epithelial cells. J. Virol. 72:5552-5558.
38. Yaswen, L. R., E. B. Stephens, L. C. Davenport, and L. M. Hutt-Fletcher. 1943. Epstein-Barr virus glycoprotein gp85 associates with the BKRF2 gene product and is incompletely processed as a recombinant protein. Virology 195:387-396.
39. Yoshiyama, H., S. Imai, N. Shimizu, and K. Takada. 1997. Epstein-Barr virus infection of human gastric carcinoma cells: implication of the existence of a new virus receptor different from CD21. J. Virol. 71:5688-5691.
40. Zolotukhin, S., M. Potter, W. W. Hauswirth, J. Guy, and N. Muzyczka. 1996. A "humanized" green fluorescent protein cDNA adapted for high-level expression in mammalian cells. J. Virol. 70:4646-4654.